- Home
- / Dianthus Therapeutics
Dianthus Therapeutics
Total Funding
$136.5 M
Dianthus Therapeutics Summary
Company summary
- Overview
- Dianthus Therapeutics is a biotech company developing therapeutics and drugs to treat severe and rare autoimmune diseases. It designs and delivers monoclonal antibodies to allow people with rare and severe autoimmune diseases live healthier lives.
- Type
- Private
- Status
- Active
- Founded
- 2019
- HQ
- Waltham, MA, US | view all locations
- Website
- https://dianthustx.com/
- Cybersecurity rating
Key people
Evan Thompson, Chief Operating Officer
Edward Carr, Chief Accounting Officer
Simrat Randhawa, Chief Medical Officer
LocationsView all
2 locations detected
Waltham, MA HQ
United States
203 Crescent St 17 102b
New York, NY
United States
Footer menu
Products
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension